News

New EudraVigilance system and go-live plan Information for marketing authorisation holders and sponsors of clinical trials The European Medicines Agency (EMA) informs that on 22 November 2017, EMA will launch a new and...

New EudraVigilance system and go-live plan Information for marketing authorisation holders and sponsors of clinical trials The European Medicines Agency (EMA) informs that on 22 November 2017, EMA will launch a new and...

New feature “Biosimilar medicines” introduced in the Medicinal Product Register of LatviaIn accordance with the Cabinet of Ministers regulation regarding the procedure for prescribing recipes, the pharmacist or...

New feature “Biosimilar medicines” introduced in the Medicinal Product Register of LatviaIn accordance with the Cabinet of Ministers regulation regarding the procedure for prescribing recipes, the pharmacist or...

Frequently asked questions on medicinal products marketing authorisation The State Agency of Medicines (SAM) of Latvia launches a new subsection on the Agency’s web page Frequently asked questions under the section...

Frequently asked questions on medicinal products marketing authorisation The State Agency of Medicines (SAM) of Latvia launches a new subsection on the Agency’s web page Frequently asked questions under the section...

Terms/abbreviations for “batch number” and “expiry date” to be used on the labelling of human medicinal products: updated version of document is published The State Agency of Medicines (SAM) informs that the most recent...

Terms/abbreviations for “batch number” and “expiry date” to be used on the labelling of human medicinal products: updated version of document is published The State Agency of Medicines (SAM) informs that the most recent...

Implementation plan for the introduction of the safety features on the packaging of nationally authorised medicinal products for human use Information for marketing authorisation holders In February 2016, the Co...